Novavax Inc
NASDAQ:NVAX

Watchlist Manager
Novavax Inc Logo
Novavax Inc
NASDAQ:NVAX
Watchlist
Price: 6.41 USD Market Closed
Market Cap: 1B USD

Intrinsic Value

The intrinsic value of one NVAX stock under the Base Case scenario is 6.13 USD. Compared to the current market price of 6.41 USD, Novavax Inc is Overvalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NVAX Intrinsic Value
6.13 USD
Overvaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novavax Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NVAX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NVAX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

AI Assistant
AI Assistant
Ask me anything about Novavax Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novavax Inc

Current Assets 1.1B
Cash & Short-Term Investments 923.1m
Receivables 108.3m
Other Current Assets 97.5m
Non-Current Assets 431.5m
PP&E 300m
Intangibles 107.5m
Other Non-Current Assets 24m
Efficiency

Free Cash Flow Analysis
Novavax Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Novavax Inc

Revenue
682.2m USD
Cost of Revenue
-201.7m USD
Gross Profit
480.4m USD
Operating Expenses
-712.4m USD
Operating Income
-231.9m USD
Other Expenses
44.4m USD
Net Income
-187.5m USD
Fundamental Scores

NVAX Profitability Score
Profitability Due Diligence

Novavax Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score

Novavax Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

NVAX Solvency Score
Solvency Due Diligence

Novavax Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
40/100
Solvency
Score

Novavax Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NVAX Price Targets Summary
Novavax Inc

Wall Street analysts forecast NVAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVAX is 17.68 USD with a low forecast of 9.09 USD and a high forecast of 26.25 USD.

Lowest
Price Target
9.09 USD
42% Upside
Average
Price Target
17.68 USD
176% Upside
Highest
Price Target
26.25 USD
310% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Novavax Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NVAX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NVAX Insider Trading
Buy and sell transactions by insiders

NVAX News

Other Videos
What is the Intrinsic Value of one NVAX stock?

The intrinsic value of one NVAX stock under the Base Case scenario is 6.13 USD.

Is NVAX stock undervalued or overvalued?

Compared to the current market price of 6.41 USD, Novavax Inc is Overvalued by 4%.

Back to Top